Ivermectin Insights

Sabine shares her experience as part of a group of doctors navigating treatment protocols during the pandemic. She discusses the transition from hydroxychloroquine to ivermectin, emphasizing the importance of collaboration and data sharing among physicians. Intrigued by the microbial connections of ivermectin, she explores its potential benefits, particularly in relation to bifidobacteria, while recounting the challenges faced in clinical trials.